Doctors could predict whether a man’s prostate cancer will be aggressive at the point of diagnosis – giving him the best ...

A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

Professor Amy Berrington explains how she and a team of scientists from around the world took on the challenge of updating a classic text for cancer researchers.

Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, ...

A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to discover why at least half of all patients fail to respond to ...

Researchers are a step closer to revolutionising how doctors use radiotherapy to treat patients with muscle-invasive bladder ...

Help us reach the finishing line. Let’s finish cancer together. Are you ready to take on one of London's most famous half marathons? With closed roads and a chance to take in four of the capital's ...

Our excellence in working with industry and academia, and in engaging with the wider public has been highlighted in an important analysis. The latest Knowledge Exchange Framework – ‘KEF’ for short – ...

Professor Paul Workman’s intellectual and scientific motivation to pursue a career in cancer research has always been matched by a personal motivation too. As a leader in the field of discovering ...